Literature DB >> 34593536

Perirenal Fat Thickness Is Significantly Associated With the Risk for Development of Chronic Kidney Disease in Patients With Diabetes.

Xiangjun Chen1, Yun Mao2, Jinbo Hu1, Shichao Han3, Lilin Gong1, Ting Luo1, Shumin Yang1, Hua Qing1, Yue Wang1, Zhipeng Du1, Mei Mei1, Li Zheng1, Xinlu Lv1, Ying Tang1, Qinying Zhao1, Yangmei Zhou1, John Cijiang He4,5, Qifu Li6, Zhihong Wang6.   

Abstract

Perirenal fat is adjacent to kidneys and active in metabolism and adipokine secretion. We aimed to investigate whether perirenal fat is an independent predictor for chronic kidney disease (CKD) and compared it with total, subcutaneous, or visceral fat in patients with diabetes. Perirenal fat thickness (PRFT) was measured by computed tomography, and total body fat (TBF), subcutaneous adipose tissue (SAT), and visceral adipose tissue (VAT) were assessed by DEXA. In cross-sectional analysis, patients with higher PRFT had a lower estimated glomerular filtration rate (eGFR). Multiple linear regression analysis showed a negative correlation between PRFT and eGFR after confounders adjustment. No association between eGFR and TBF, SAT, or VAT was observed. Longitudinally, 190 patients with type 2 diabetes mellitus (T2DM) without CKD at baseline were followed for 2 years. A total of 29 participants developed CKD. After VAT-based multivariate adjustment, each SD (per-SD) increment in baseline PRFT was associated with a higher incidence of CKD (hazard ratio 1.67, 95% CI 1.04-2.68), while TBF, SAT, and VAT were not. Furthermore, PRFT predicted CKD, with a C-statistic (95% CI) of 0.668 (0.562, 0.774), which was higher than that of TPF [0.535 (0.433, 0.637)], SAT [0.526 (0.434, 0.618)], and VAT [0.602 (0.506, 0.698)]. In conclusion, with perirenal fat there was a higher predictive value for CKD than with total, subcutaneous, or visceral fat in T2DM.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2021        PMID: 34593536     DOI: 10.2337/db20-1031

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  4 in total

1.  Perirenal Fat Thickness: A Surrogate Marker for Metabolic Syndrome in Chinese Newly Diagnosed Type 2 Diabetes.

Authors:  Xiu Li Guo; Mei Tu; Yang Chen; Wei Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-16       Impact factor: 5.555

2.  Perirenal Fat Thickness Significantly Associated with Prognosis of Metastatic Renal Cell Cancer Patients Receiving Anti-VEGF Therapy.

Authors:  Kang Ning; Zhen Li; Huiming Liu; Xi Tian; Jun Wang; Yi Wu; Longbin Xiong; Xiangpeng Zou; Yulu Peng; Zhaohui Zhou; Fangjian Zhou; Chunping Yu; Junhang Luo; Hailiang Zhang; Pei Dong; Zhiling Zhang
Journal:  Nutrients       Date:  2022-08-18       Impact factor: 6.706

3.  The perirenal fat thickness was independently associated with serum uric acid level in patients with type 2 diabetes mellitus.

Authors:  Yuxian Yang; Yan Ma; Yanan Cheng; Yuechao Xu; Yuan Fang; Jing Ke; Dong Zhao
Journal:  BMC Endocr Disord       Date:  2022-08-20       Impact factor: 3.263

4.  Renal fat fraction is significantly associated with the risk of chronic kidney disease in patients with type 2 diabetes.

Authors:  Yan Shen; Lianghua Xie; Xiangjun Chen; Lina Mao; Yao Qin; Rui Lan; Shumin Yang; Jinbo Hu; Xue Li; Hanwen Ye; Wenjin Luo; Lilin Gong; Qifu Li; Yun Mao; Zhihong Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.